Serum Institute has applied for full market authorisation of Covishield: CEO Adar Poonawala

Serum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla informed in a tweet on Friday. Serum Institute, which produces AstraZeneca's Covid-19 vaccine under the brand name Covishield, has supplied more than 1.25 billion doses of the vaccine in India.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3EBiFJS
https://ift.tt/3JpwG0V